Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)

The National Institutes of Health is seeking applications for institutional training programs to advance translational research on Alzheimer's disease and Alzheimer's-related dementias. The program aims to support the development of a diverse, interdisciplinary workforce needed to conduct translational research from target discovery through clinical development. Eligible institutions can apply to develop interdisciplinary training programs that will provide trainees with the knowledge and skills necessary to conduct rigorous and cutting-edge basic, translational, and clinical research for AD/ADRD. • The program will support predoctoral and postdoctoral level researchers with diverse educational backgrounds. • The training programs should provide trainees with knowledge and skills in data science, disease biology, behavioral research, and traditional and emerging drug discovery disciplines. • Eligible applicants include private institutions of higher education, public and state-controlled institutions of higher education, and other organizations. • The opportunity is for a grant, and the application deadline is September 25, 2026.